A clinical trial held at OU Health showed promising results for proton therapy for certain types of head and neck cancer.

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...

Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...

Head and neck cancers represent 4% of U.S. cancer cases, with significant mortality rates, highlighting the need for awareness and early detection. These cancers affect multiple anatomical sites, ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...

While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee and tea we drink can have a protective effect, reducing the risk of ...

Merus has reported a 79% 12-month survival rate in cancer patients on its bispecific antibody, cementing William Blair analysts' belief the candidate has a “best-in-disease profile.” The bispecific ...

Tumors of the middle ear and temporal bone are uncommon, and determining their primary site is often challenging. Due to their proximity to the skull base, nasopharynx, and paranasal sinuses, the ...